Publications
4 shownTrial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease
Solanezumab at a dose of 400 mg administered every 4 weeks in patients with mild Alzheimer's disease did not significantly affect cognitive decline. (Funded by Eli Lilly; EXPEDI...
α2 Macroglobulin and the risk of Alzheimer’s disease
Our data support an association between the A2M gene and AD. This association is less pronounced, however, in our cohort than in the previously reported sample of sibpairs.
Dementia incidence declined in African‐Americans but not in Yoruba
Abstract Introduction To compare dementia incidence of African‐American and Yoruba cohorts aged ≥70 years enrolled in 1992 and 2001. Methods African‐Americans residing in Indian...
Frequent Co-Authors
Researcher Info
- h-index
- 4
- Publications
- 4
- Citations
- 1,176
- Institution
- Indiana University
External Links
Identifiers
- ORCID
- 0000-0001-7134-5485
Impact Metrics
h-index
4
h-index: Number of publications with at least h citations each.